NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $383.05M 135 sales by 12 insiders
- Filings on record
- 783 since 2021-07-07, latest 2026-09-25 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $29.84M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,059
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-29 | 2023-03-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +1,364 | 177.2K | +0.8% | — |
| D | 2023-03-29 | 2023-03-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $55.13 | -731 | 176.4K | -0.4% | -$40.3K |
| D | 2023-03-29 | 2023-03-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +447 | 529.9K | +0.1% | — |
| D | 2023-03-29 | 2023-03-28 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $55.13 | -134 | 529.7K | -0.0% | -$7,387 |
| DM | 2023-03-24 | 2023-03-22+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $56.29 | -3,338 | 175.8K | -2% | -$187.9K |
| D | 2023-03-24 | 2023-03-22 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +893 | 176.3K | +0.5% | — |
| D | 2023-03-24 | 2023-03-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,078 | 65.9K | +2% | — |
| DM | 2023-03-24 | 2023-03-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $55.98 | -2,451 | 64.8K | -4% | -$137.2K |
| DM | 2023-03-24 | 2023-03-22+ | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale+OE | $56.31 | -2,604 | 640.1K | -0.4% | -$146.6K |
| D | 2023-03-24 | 2023-03-22 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | — | +401 | 640.2K | +0.1% | — |
| D | 2023-03-24 | 2023-03-22 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +455 | 529.6K | +0.1% | — |
| DM | 2023-03-24 | 2023-03-22+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $56.30 | -1,394 | 529.4K | -0.3% | -$78.5K |
| DM | 2023-03-24 | 2023-03-22+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $56.02 | -8,043 | 209.8K | -4% | -$450.5K |
| DM | 2023-03-24 | 2023-03-22 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,307 | 210.0K | +2% | — |
| 2023-03-21 | 2023-03-17 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +3,442 | 66.2K | +5% | — | |
| 2023-03-21 | 2023-03-17 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +2,864 | 178.3K | +2% | — | |
| 2023-03-21 | 2023-03-17 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +9,427 | 214.6K | +5% | — | |
| 2023-03-21 | 2023-03-17 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +1,259 | 530.4K | +0.2% | — | |
| 2023-03-21 | 2023-03-17 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | A - Grant | — | +2,484 | 642.3K | +0.4% | — | |
| M | 2023-03-03 | 2023-03-02 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $55.96 | -9,312 | 175.4K | -5% | -$521.1K |
| 2023-03-03 | 2023-03-02 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $55.00 | -40.8K | 205.1K | -17% | -$2.25M | |
| D | 2023-03-01 | 2023-02-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +2,289 | 529.1K | +0.4% | — |
| D | 2023-03-01 | 2023-02-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +10.3K | 190.2K | +6% | — |
| D | 2023-03-01 | 2023-02-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $48.94 | -5,498 | 184.7K | -3% | -$269.1K |
| D | 2023-03-01 | 2023-02-28 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $48.94 | -5,218 | 62.8K | -8% | -$255.4K |
| D | 2023-03-01 | 2023-02-27 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +18.3K | 68.0K | +37% | — |
| D | 2023-03-01 | 2023-02-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $48.94 | -13.5K | 246.0K | -5% | -$659.4K |
| D | 2023-03-01 | 2023-02-27 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +28.4K | 259.4K | +12% | — |
| M | 2023-02-01 | 2023-01-30+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $42.47 | -103.0K | 69.0K | -60% | -$4.38M |
| 2023-01-31 | 2023-01-27 | NTRA | Schueren Robert Alan | COO | A - Grant | — | +19.9K | 24.1K | +470% | — | |
| 2023-01-31 | 2023-01-27 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +49.7K | 152.7K | +48% | — | |
| 2023-01-31 | 2023-01-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +31.0K | 179.9K | +21% | — | |
| 2023-01-31 | 2023-01-27 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +127.3K | 231.0K | +123% | — | |
| 2023-01-31 | 2023-01-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +6,208 | 526.8K | +1% | — | |
| D | 2023-01-24 | 2023-01-23 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $41.56 | -2,387 | 148.9K | -2% | -$99.2K |
| DM | 2023-01-24 | 2023-01-20+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +4,068 | 150.6K | +3% | — |
| D | 2023-01-24 | 2022-12-29 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | G - Gift | $0.00 | -50.3K | 519.8K | -9% | $0 |
| DM | 2023-01-24 | 2023-01-20+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +903 | 520.7K | +0.2% | — |
| D | 2023-01-24 | 2023-01-23 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $41.56 | -51 | 520.6K | -0.0% | -$2,120 |
| DI | 2023-01-24 | 2023-01-12 | NTRA | Schueren Robert Alan | COO | G - Gift | $0.00 | -1,100 | 114.1K | -1.0% | $0 |
| D | 2023-01-24 | 2023-01-23 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $41.56 | -4,256 | 4,226 | -50% | -$176.9K |
| DM | 2023-01-24 | 2023-01-20+ | NTRA | Schueren Robert Alan | COO | M - OptEx | — | +8,482 | 7,232 | New | — |
| DM | 2023-01-24 | 2023-01-20+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +15.3K | 109.1K | +16% | — |
| D | 2023-01-24 | 2023-01-23 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $41.56 | -5,370 | 103.8K | -5% | -$223.2K |
| D | 2023-01-24 | 2023-01-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $41.56 | -2,273 | 103.0K | -2% | -$94.5K |
| DM | 2023-01-24 | 2023-01-20+ | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +8,482 | 104.0K | +9% | — |
| 2023-01-18 | 2023-01-13 | NTRA | HEALY JAMES | Dir | A - Grant | $40.01 | +390 | 34.9K | +1% | +$15.6K | |
| I | 2023-01-18 | 2022-11-16 | NTRA | HEALY JAMES | Dir | S - Sale | $37.71 | -2,400 | 0 | -100% | -$90.5K |
| 2023-01-18 | 2023-01-13 | NTRA | Baynes Roy D. | Dir | A - Grant | $40.01 | +312 | 5,094 | +7% | +$12.5K | |
| 2023-01-18 | 2023-01-13 | NTRA | ROSENMAN HERM | Dir | A - Grant | $40.01 | +453 | 53.9K | +0.8% | +$18.1K | |
| D | 2023-01-18 | 2023-01-13 | NTRA | Marcus Gail Boxer | Dir | A - Grant | $40.01 | +203 | 8,930 | +2% | +$8,122 |
| DM | 2023-01-10 | 2023-01-07+ | NTRA | Schueren Robert Alan | COO | M - OptEx | $13.01 | +7,923 | 11.8K | +203% | +$103.1K |
| D | 2023-01-10 | 2023-01-09 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $37.62 | -2,244 | 7,886 | -22% | -$84.4K |
| D | 2023-01-04 | 2023-01-03 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $39.55 | -3,644 | 96.8K | -4% | -$144.1K |
| D | 2023-01-04 | 2022-12-31 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +9,108 | 100.5K | +10% | — |
| D | 2023-01-04 | 2023-01-03 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $39.55 | -1,236 | 570.1K | -0.2% | -$48.9K |
| D | 2023-01-04 | 2022-12-31 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +4,141 | 571.3K | +0.7% | — |
| D | 2023-01-04 | 2023-01-03 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $39.55 | -4,856 | 6,145 | -44% | -$192.1K |
| D | 2023-01-04 | 2022-12-31 | NTRA | Schueren Robert Alan | COO | M - OptEx | — | +9,634 | 11.0K | +705% | — |
| D | 2023-01-04 | 2023-01-03 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale+OE | $39.55 | -2,706 | 639.8K | -0.4% | -$107.0K |
| D | 2023-01-04 | 2022-12-31 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | — | +6,763 | 642.5K | +1% | — |
| DM | 2023-01-04 | 2022-12-31+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +16.8K | 102.0K | +20% | — |
| D | 2023-01-04 | 2023-01-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $39.55 | -8,212 | 93.8K | -8% | -$324.8K |
| D | 2022-12-29 | 2022-12-27 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +1,363 | 147.9K | +0.9% | — |
| D | 2022-12-29 | 2022-12-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $39.84 | -728 | 147.2K | -0.5% | -$29.0K |
| D | 2022-12-29 | 2022-12-28 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $39.84 | -134 | 567.2K | -0.0% | -$5,339 |
| D | 2022-12-29 | 2022-12-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +447 | 567.3K | +0.1% | — |
| D | 2022-12-29 | 2022-12-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $39.84 | -2,605 | 85.2K | -3% | -$103.8K |
| D | 2022-12-29 | 2022-12-27 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +5,183 | 87.8K | +6% | — |
| D | 2022-12-29 | 2022-12-27 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +2,291 | 92.3K | +3% | — |
| D | 2022-12-29 | 2022-12-28 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $39.84 | -915 | 91.3K | -1.0% | -$36.5K |
| DI | 2022-12-29 | 2022-12-29 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $40.37 | -5,897 | 103.4K | -5% | -$238.1K |
| D | 2022-12-29 | 2022-12-28 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $39.84 | -1,382 | 1,367 | -50% | -$55.1K |
| D | 2022-12-29 | 2022-12-27 | NTRA | Schueren Robert Alan | COO | M - OptEx | — | +2,749 | 2,749 | New | — |
| D | 2022-12-27 | 2022-12-22 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | M - OptEx | — | +400 | 635.7K | +0.1% | — |
| D | 2022-12-27 | 2022-12-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,077 | 90.4K | +1% | — |
| D | 2022-12-27 | 2022-12-23 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $42.30 | -429 | 90.0K | -0.5% | -$18.1K |
| D | 2022-12-27 | 2022-12-22 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +892 | 147.0K | +0.6% | — |
| D | 2022-12-27 | 2022-12-23 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $42.30 | -476 | 146.5K | -0.3% | -$20.1K |
| DM | 2022-12-27 | 2022-12-22 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,307 | 81.2K | +4% | — |
| D | 2022-12-27 | 2022-12-23 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $42.30 | -1,660 | 82.6K | -2% | -$70.2K |
| D | 2022-12-27 | 2022-12-22 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +455 | 567.0K | +0.1% | — |
| D | 2022-12-27 | 2022-12-23 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $42.30 | -136 | 566.9K | -0.0% | -$5,753 |
| DM | 2022-12-09 | 2022-12-07 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $9.70 | +10.3K | 83.6K | +14% | +$100.0K |
| D | 2022-12-09 | 2022-12-07 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $38.31 | -2,645 | 81.0K | -3% | -$101.3K |
| D | 2022-10-25 | 2022-10-21 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +644 | 146.5K | +0.4% | — |
| D | 2022-10-25 | 2022-10-24 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $42.41 | -350 | 146.1K | -0.2% | -$14.8K |
| DM | 2022-10-25 | 2022-10-21+ | NTRA | Schueren Robert Alan | COO | M - OptEx | — | +6,145 | 3,067 | New | — |
| D | 2022-10-25 | 2022-10-24 | NTRA | Schueren Robert Alan | COO | S - Sale+OE | $42.41 | -3,135 | 4,932 | -39% | -$133.0K |
| DM | 2022-10-25 | 2022-10-21+ | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +6,145 | 91.8K | +7% | — |
| D | 2022-10-25 | 2022-10-24 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $42.41 | -2,488 | 89.3K | -3% | -$105.5K |
| D | 2022-10-25 | 2022-10-24 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $42.41 | -44 | 566.5K | -0.0% | -$1,866 |
| D | 2022-10-25 | 2022-10-21 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +143 | 566.6K | +0.0% | — |
| D | 2022-10-25 | 2022-10-21 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +1,774 | 74.2K | +2% | — |
| D | 2022-10-25 | 2022-10-24 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $42.41 | -905 | 73.3K | -1% | -$38.4K |
| D | 2022-10-19 | 2022-10-18 | NTRA | Schueren Robert Alan | COO | M - OptEx | $13.01 | +1,922 | 1,922 | New | +$25.0K |
| 2022-10-18 | 2022-10-14 | NTRA | ROSENMAN HERM | Dir | A - Grant | $45.42 | +399 | 53.5K | +0.8% | +$18.1K | |
| 2022-10-18 | 2022-10-14 | NTRA | HEALY JAMES | Dir | A - Grant | $45.42 | +344 | 34.6K | +1% | +$15.6K | |
| D | 2022-10-18 | 2022-10-14 | NTRA | Marcus Gail Boxer | Dir | A - Grant | $45.42 | +178 | 8,727 | +2% | +$8,085 |
| 2022-10-18 | 2022-10-14 | NTRA | Chapman Rowan E | Dir | A - Grant | $45.42 | +330 | 6,854 | +5% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations